The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Dynavax Technologies Corporation(NASDAQ:DVAX) 
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older ...
Website: http://www.dynavax.com
Founded: 1996
Full Time Employees: 231
Sector: Healthcare
Industry: Biotechnology
Dynavax Technologies Days Payable Outstanding ttm (DPO)
Dynavax Technologies Days Receivable Outstanding ttm (DSO)
Dynavax Technologies Days Inventory Outstanding ttm (DIO)
Dynavax Technologies Op Cashflow Per Share ttm
Dynavax Technologies Free Cashflow Per Share ttm
Dynavax Technologies Cash Per Share ttm
Dynavax Technologies P/S ratio ttm
Dynavax Technologies (GAAP) P/E ratio ttm
Dynavax Technologies P/B ratio ttm
No extra charts and metrics for this ticker.